Johnson & Johnson will acquire medical-device maker Synthes for $21.3 billion, giving the U.S. health-products giant a ...

April 16 (Reuters) - Johnson & Johnson's (JNJ.N), opens new tab first-quarter revenue missed Wall Street estimates for medical devices on Tuesday and sales of its blockbuster psoriasis drug Stelara ...

The complete study cohort includes 1,023 patients from 22 sites in Europe.

Johnson & Johnson (NYSE:JNJ) is in talks to buy Synthes Inc. for $20 billion, according to a report in the Wall Street Journal. The Journal, citing anonymous sources with knowledge of the situation, ...

(Reuters) -Johnson & Johnson on Friday agreed to buy Shockwave Medical in a deal valued at $13.1 billion including debt, as it builds its cardiac-health-centric medical devices business to help drive ...

Johnson & Johnson announced Friday it will buy medical device maker Shockwave Medical for nearly $13.1 billion in a move the company hopes will help it further combat heart disease. Founded in 1886, J ...

NJBIZ, New Jersey’s leading business journal, provides 24/7 business news coverage and events honoring top business professionals.

(Bloomberg) -- Johnson & Johnson agreed to acquire Shockwave Medical Inc. for about $13.1 billion to bolster its expansion into making medical devices to treat heart disease. J&J will pay $335 a share ...

BOSTON, Dec 14 (Reuters) - A federal appeals court on Thursday upheld the convictions of two former executives of Acclarent Inc, a medical device maker now owned by Johnson & Johnson, for distributing ...

We are holding our $164 fair value estimate for J&J steady after its agreement to acquire Shockwave Medical for close to $13 billion. We believe the growth potential of Shockwave will help accelerate ...